Stay
up-to-date
about
RECOVER
Our understanding of Long COVID is constantly evolving with new research findings. Stay informed by reading the latest news and participating in upcoming events.
In 2024, RECOVER continued to advance scientific understanding of Long COVID through observational studies, clinical trials, and community engagement.
A RECOVER pathobiology study advances our understanding of how SARS-CoV-2, the virus that causes COVID-19, might also cause Long COVID.
Data provided by more than 3,800 new study participants reinforce how the long-term effects of COVID-19 can be different for everyone.
Using a large and diverse collection of tissue samples, experts in how diseases affect different parts of the body will explore the underlying causes of Long COVID.
Editorial by NIH leaders shares how RECOVER has worked and will continue working to ease the suffering of those living with Long COVID.
The $662 million in funds received in 2024 will ensure that researchers can continue making progress toward understanding, diagnosing, preventing, and treating Long COVID through 2029.
Findings from studies sponsored by NIH’s Collaborative Cohort of Cohorts for COVID-19 Research (C4R) could inform future efforts to prevent COVID-19 and Long COVID.
Researchers can learn how to access and use data from RECOVER’s pediatric observational study during the next BioData Catalyst® (BDC) Community Hours event, scheduled for Tuesday, December 3rd, 2024, at 1:00 pm EST.
Media InquiriesAre you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in your subject line.